Off the wire
Indonesia keeps interest rate unchanged as inflation pressure mounts  • Albania asked to advance rule of law for its EU accession bid  • 1st LD: Car bomb rocks central Afghan capital  • Chinese academician helps paper plants realize zero discharge of waste  • Italian football faces new match-fixing scandal  • Ukraine's Opposition Bloc party calls for lifting communist ideology ban  • News Analysis: Lack of defense minister hobbles Afghanistan's fight against Taliban  • Feature: Book industry becomes another victim of debt crisis in Greece  • Gaza farmers, fishermen protest against Israel  • Indonesian envoy wounded in chopper crash in Pakistan passes away  
You are here:   Home

Chinese biologists find key process to obtain adult stem cells

Xinhua, May 19, 2015 Adjust font size:

The Chinese Academy of Sciences (CAS) announced scientists have discovered a new method for reprogramming and obtaining induced pluripotent stem cells (iPS cells), or stem cells derived from adult cells.

The latest research by stem-cell biologist Pei Duanqing and his team revealed autophagy, a process in generating iPS, does not play a vital role in reprogramming. Previously, it was believed it did.

Autophagy, or self-cannibalization, refers to a process of cells discarding or degrading cellular components under certain conditions to prevent further damage.

It is not only unnecessary for the process, but may hold back it, according to the finding.

"Cells that did not undergo the process of autophagy had higher efficiency of reprogramming, and iPS cells generated without the autophagy also have their normal pluripotent feature," Pei said.

Instead, they discovered that reprogramming is the inhibition of a substance called "mechanistic target of rapamycin complex 1 (mTORC1)."

Like embryonic stem cells, iPS stem cells can develop into any cell in the human body.

Shinya Yamanaka, a professor at Kyoto University, won a Nobel Prize in physiology for developing an iPS cell harvesting technique that allows stem cells to be obtained from adult tissue instead of from embryos in 2012, thus avoiding the ethical and legal barriers.

The scientists believe their findings can help people understand how cell reprogramming affects patients of metabolic diseases such as diabetes or cancer, according to a statement of the CAS.

The latest study was published by on Nature Cell Biology Monday. Endi